Joined Today: 0

MCET MultiCell Technologies, Stock Message Board

All Messages

MCET Message Board Home | Join The MCET Group |

#67: MCET Stock News : MultiCell Technologies is Granted U.S. Patent for Immortalized Human Liver Cell Lines
TheMachine	August 21, 2009 08:42:28 AM
MultiCell Strengthens Its Liver Cancer Drug Target Identification and Cancer Stem Cell Research ProgramWOONSOCKET, R.I., Aug. 20 /PRNewswire-FirstCall/ -- MultiCell Technologies, Inc. (OTC Bulletin... view message ignore post recommend post

#66: MCET Stock News : MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
TheMachine	May 26, 2009 01:15:06 AM
WOONSOCKET, R.I., March 19 /PRNewswire-FirstCall/ --MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) announced today that it has entered into a cooperative research and development... view message ignore post recommend post

#65: MultiCell Technologies To Increase Focus on Therapeutic Candidates
Stock News Bot	February 27, 2008 07:32:28 AM
Stephen Chang, Ph.D. resigns; W. Gerald Newmin, Chairman, appointed Interim Chief Executive Officer and President LINCOLN, R.I., Dec. 26 /PRNewswire-FirstCall/ -- MultiCell Technologies,... view message ignore post recommend post

#64: Interview with Steven Chang
StockPro	April 5, 2007 03:07:02 PM
President and CEO of Multicell Technologies, Inc. Steven Chang's interview is now online at Wall Street Reporter website view message ignore post recommend post

#63: MCET News MultiCell Technologies' Proprietary Breakthrough Anti-Cancer Therapy Shown to Prevent Recurrence of Cancer
Stock News Bot	January 11, 2007 03:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation technologies, has announced that the... view message ignore post recommend post

#62: MCET News MultiCell Technologies Fulfills Upfront License Fee Payment Obligation to Amarin Neuroscience for MCT-125
Stock News Bot	December 15, 2006 03:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#61: MCET News MultiCell Technologies Discusses Recent Cancer Treatment Breakthrough and Growing Intellectual Property Portfolio with CEOcast.com Investor Information Service
Stock News Bot	December 6, 2006 02:04:00 PM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#60: MCET News MultiCell Technologies Obtains Patent Protection in Several European Countries for Treatment of Autoimmune Diseases
Stock News Bot	November 29, 2006 03:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#59: MCET News MultiCell Technologies Releases CEO Letter to Shareholders
Stock News Bot	November 27, 2006 01:01:00 PM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#58: MCET News WebAlert: MultiCell Technologies Presenting during SmallCapInsights.com's ''Emerging Growth Forum'' Starting Today at 12 Noon ET
Stock News Bot	November 22, 2006 03:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), along with SmallCapInsights.com, a leading investment newsletter committed to discovering tomorrow's smallcap... view message ignore post recommend post

#57: MCET News Multicell Technologies Demonstrates Drug Candidate's Powerful Tumor-Destroying Capabilities for Virally Induced Cancers such as Cervical Cancer
Stock News Bot	November 21, 2006 06:25:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#56: MCET News MultiCell Technologies and SmallCapInsights.com Highlight CEOs Presenting at Wednesday's Anticipated ``Emerging Growth Forum''
Stock News Bot	November 20, 2006 07:06:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. [OTCBB:MCET], along with SmallCapInsights.com, a leading investment newsletter committed to discovering tomorrow's smallcap... view message ignore post recommend post

#55: MCET News MultiCell Technologies to Seek Advanced Human Clinical Trials for Lead Therapeutics Program
Stock News Bot	November 20, 2006 06:25:00 AM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

#54: MCET News MultiCell Technologies Announces SmallCapInsights.com to Host ``Emerging Growth Forum'' Webcast Highlighting Auriga Laboratories, MultiCell Technologies, Peace Arch Entertainment and Titan Global Holdings
Stock News Bot	November 16, 2006 07:04:00 AM
SAN DIEGO--(BUSINESS WIRE)--SmallCapInsights.com, a leading investment newsletter committed to discovering tomorrow's smallcap breakthroughs, has announced that its Emerging Growth... view message ignore post recommend post

#53: MCET News MultiCell Technologies CEO to Present Key Research Data at New York Academy of Sciences' Animal Models Conference
Stock News Bot	November 7, 2006 01:01:00 PM
SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies,... view message ignore post recommend post

Group Home | Login if you want to post a message